| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 18.05.
| JP Morgan startet Ziopharm Oncology mit overweight. | | 58 | BörseGo |
| JP Morgan startet Ziopharm Oncology mit overweight.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
JP Morgan startet Ziopharm Oncology mit overweight. | |
| 08.05.
| ZIOPHARM Oncology Appoints Jason A. Amello as Executive Vice President and Chief Financial Officer | | - | Benzinga.com |
| 02.04.
| ZIOPHARM Oncology (ZIOP) Presents Encouraging IL-12, IFNo Data | | 2 | StreetInsider.com |
| 02.04.
| ZIOPHARM Oncology (ZIOP) Updates on PICASSO 3, Sees PFS Being Achieved in H212 | | 1 | StreetInsider.com |
| 02.04.
| Ziopharm Says Picasso 3 Trial Approaches 90% Completion | | 1 | Benzinga.com |
| 27.03.
| ZIOPHARM (ZIOP) to Present Data from Four Cancer Treatment Studies at ACC 12 | | 2 | StreetInsider.com |
| 13.02.
| ZIOPHARM (ZIOP) Reports Positive Preliminary Results from Palifosfamide + Doxorubicin Phase 2 | | 1 | StreetInsider.com |
| 06.02.
| ZIOPHARM (ZIOP) NDA for Zymafos Accepted by U.S. FDA | | 1 | StreetInsider.com |
| 30.01.
| UPDATE 1-Ziopharm to continue cancer drug trial | | 1 | Reuters.com |
| 30.01.
| ZIOPHARM (ZIOP) Gets Nod from IDMC to Continue Palifosfamide PICASSO 3 | | 1 | StreetInsider.com |
| 21.12.
| ZIOPHARM Oncology to Present at the 30th Annual J.P. Morgan Healthcare Conference | | 25 | Business Wire |
| ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, M.D., Ph.D., Chief Executive Officer, will present at the
upcoming 30th Annual J.P. Morgan...
Mehr lesen zu:
ZIOPHARM Oncology to Present at the 30th Annual J.P. Morgan Healthcare Conference | |
| 08.12.
| ZIOPHARM Oncology to Present at the Oppenheimer 22nd Annual Healthcare Conference | | 30 | Business Wire |
| ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, M.D., Ph.D., Chief Executive Officer, will present at the
Oppenheimer 22nd Annual Healthcare...
Mehr lesen zu:
ZIOPHARM Oncology to Present at the Oppenheimer 22nd Annual Healthcare Conference | |
| 07.12.
| ZIOPHARM's (ZIOP) Zymafos Gets European Patent Allowance | | 1 | StreetInsider.com |
| 07.12.
| ZIOPHARM Granted European Patent Allowance for Palifosfamide | | 26 | Business Wire |
| --Additional Patent Issuance for Darinaparsin--
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has
received an allowance from the European...
Mehr lesen zu:
ZIOPHARM Granted European Patent Allowance for Palifosfamide | |
